Regulatory Updates on Compounded Peptides New Drug Loft and VLS Pharmacy FDA Peptide Reclassification 2026: What Researchers Want FDA Adds Several Peptides to Category 2 Bulks List, Restricting Them From Compounding Restore Health Consulting The FDA just changed the rules on peptides effective April 15, 2026. BPC 157, GHK Cu, MOTS C, and TB 500 have been removed from the Category 2 restricted compounding list. Here is what peptides #fda #longevity #glp1 #precisionmedicine #compounding Katherine Erickson FDA Peptide Update: Category 2 Removals Explained